Evidence map›Paper›PMID 40126137›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Vessel-On-A-Chip Coupled Proteomics Reveal Pressure-Overload-Induced Vascular Remodeling.

Yanjun Liu, Jianxujie Zheng, Lingyan Zhong, Zengyu Wang, Dan Zhao, Hong Lin, Xiaoxue Zhang, Ke Meng, Xiaoxia Yang, Dongxue Zhang and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Vessel-On-A-Chip Coupled Proteomics Reveal Pressure-Overload-Induced Vascular Remodeling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yanjun LiuDepartment of Chemistry, Zhongshan Hospital, Fudan University, Shanghai, 200000, China.
Jianxujie ZhengDepartment of Chemistry, Zhongshan Hospital, Fudan University, Shanghai, 200000, China.
Lingyan ZhongDepartment of Chemistry, Zhongshan Hospital, Fudan University, Shanghai, 200000, China.
Zengyu WangDepartment of Chemistry, Zhongshan Hospital, Fudan University, Shanghai, 200000, China.
Dan ZhaoDepartment of Chemistry, Zhongshan Hospital, Fudan University, Shanghai, 200000, China.
Hong LinDepartment of Chemistry, Zhongshan Hospital, Fudan University, Shanghai, 200000, China.
Xiaoxue ZhangDepartment of Chemistry, Zhongshan Hospital, Fudan University, Shanghai, 200000, China.
Ke MengDepartment of Neurosurgery, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, Fujian, 361015, China.
Xiaoxia YangDepartment of Chemistry, Zhongshan Hospital, Fudan University, Shanghai, 200000, China.
Dongxue ZhangDepartment of Chemistry, Zhongshan Hospital, Fudan University, Shanghai, 200000, China.
Ling LinDepartment of Chemistry, Zhongshan Hospital, Fudan University, Shanghai, 200000, China.ORCID https://orcid.org/0000-0002-6766-5432
Liang QiaoDepartment of Chemistry, Zhongshan Hospital, Fudan University, Shanghai, 200000, China.ORCID https://orcid.org/0000-0002-6233-8459

Funding

National Natural Science Foundation of China 22374031Science and Technology Commission of Shanghai Municipality 23JS1400100Science and Technology Commission of Shanghai Municipality 24ZR1410800
6 · The paper itself

Abstract

Hypertension, the leading cause of cardiovascular disease and premature mortality, is characterized by increased vessel stretch and alterations in vascular smooth muscle cells (VSMCs). In this study, a vessel-on-a-chip model is developed to simulate both physiological and pathological stretch conditions alongside a mouse model of hypertension. Proteomics analysis is applied to investigate changes in VSMCs using the vessel-on-a-chip system and compared these findings with data from the mouse model. The results demonstrates that physiological stretch enhances the expression of contractile markers in VSMCs. Additionally, the chip effectively replicates cellular responses to pathological stretch and stress, including the upregulation of ERK signaling, calcium ion transport pathway, integrin signaling pathway, endoplasmic reticulum stress, toll-like receptor activation, oxidative stress, and synthesis of sphingolipids and ceramides. These findings indicate that the vessel chip successfully mimics in vivo biological events associated with hypertension. The vessel-on-a-chip system holds promise for advancing the study of vessel-related diseases and facilitating the development of novel hypertension therapeutics.

Indexed as

HypertensionLab-On-A-Chip DevicesMuscle, Smooth, VascularProteomicsVascular RemodelingAnimalsDisease Models, AnimalMaleMiceMice, Inbred C57BLMyocytes, Smooth MuscleSignal Transductionhypertensionmicrofluidicsproteomicssmooth muscle cellsvessel‐on‐a‐chip

Identifiers

PMID40126137
PMCPMC12097099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.